Regenxbio Inc (RGNX)
7.40
+0.02
(+0.27%)
USD |
NASDAQ |
Dec 24, 16:00
Regenxbio Free Cash Flow: -184.74M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 221.79M |
| Vertex Pharmaceuticals Inc | -1.352B |
| Sarepta Therapeutics Inc | -480.40M |
| Edgewise Therapeutics Inc | -110.10M |
| Entrada Therapeutics Inc | -17.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.55M |
| Cash from Investing (Quarterly) | 50.26M |
| Cash from Financing (Quarterly) | -10.86M |
| Free Cash Flow Per Share (Quarterly) | -0.8046 |
| Free Cash Flow to Equity (Quarterly) | -40.88M |
| Free Cash Flow Yield | -52.25% |